Explore the full insider trade history of IGC Pharma, Inc., a listed issuer based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Market capitalisation: €29.5m. The latest transaction was filed on 27 September 2024 (Acquisition). Among the most active insiders: Moran James P. All data is openly available.
11
Insider Decl.
0
Thresholds
€179,678
1 ops.
Buy Volume
·
0 ops.
Sell Volume
29Σ signal
Buys €179,678· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.